⌘K

Home/Filings/4/0001209191-12-050018

4//SEC Filing

Clendeninn Neil James 4

Accession 0001209191-12-050018

CIK 0000949858other

View on SEC.gov Company Profile

Filed

Oct 18, 8:00 PM ET

Accepted

Oct 19, 3:01 PM ET

Size

6.8 KB

Accession

0001209191-12-050018

Insider Transaction Report

Form 4

Period: 2012-10-18

ONCOGENEX PHARMACEUTICALS, INC.OGXI

Clendeninn Neil James

Director

Transactions

Exercise/Conversion
Common Stock
2012-10-18$4.11/sh+513$2,106→ 7,562 total
Exercise/Conversion
Stock Option
2012-10-18−513→ 0 total
Exercise: $4.11From: 2006-03-23Exp: 2013-03-23→ Common Stock (513 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ONCOGENEX PHARMACEUTICALS, INC.

CIK 0000949858

Entity typeother

Related Parties

1

filerCIK 0001442443

Filing Metadata

Form type: 4
Filed: Oct 18, 8:00 PM ET
Accepted: Oct 19, 3:01 PM ET
Size: 6.8 KB

View on SEC.gov